SALL4 and neuroblastoma: In KELLY cells, a neuroblastoma line, pomalidomide induced robust downregulation of the developmental transcription factor SALL4 (32) and ZFP91 (31), while PT-179 exhibited no significant degradation of detected proteins (fig.